FIBROGEN INC - COMMON STOCK

Astellas Receives Positive CHMP Opinion for EVRENZO™ (roxadustat) for Adult Patients with Symptomatic Anemia of Chronic Kidney Disease

25 июн 2021 09:15:00 Источник Nasdaq GlobeNewswire

FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease

17 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

Pamrevlumab Included in Pancreatic Cancer Action Network’s Adaptive Clinical Trial Platform

16 июн 2021 08:00:01 Источник Nasdaq GlobeNewswire

FibroGen to Present at Upcoming Investor Conferences

27 май 2021 07:00:00 Источник Nasdaq GlobeNewswire

FibroGen Reports First Quarter 2021 Financial Results

10 май 2021 16:01:00 Источник Nasdaq GlobeNewswire

FibroGen to Report First Quarter 2021 Financial Results

03 май 2021 07:00:00 Источник Nasdaq GlobeNewswire

FibroGen to Present at Upcoming Investor Conference

28 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

FibroGen Receives Rare Pediatric Disease Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

15 апр 2021 07:00:00 Источник Nasdaq GlobeNewswire

FibroGen Receives Fast Track Designation from the U.S. FDA for Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

12 апр 2021 07:00:01 Источник Nasdaq GlobeNewswire

FibroGen Announces FDA Advisory Committee to Review Roxadustat New Drug Application Tentatively Scheduled for July 15, 2021

06 апр 2021 19:50:31 Источник Nasdaq GlobeNewswire

FibroGen Provides Additional Information on Roxadustat

06 апр 2021 16:01:00 Источник Nasdaq GlobeNewswire

FibroGen Initiates LELANTOS-2 – Second Phase 3 Clinical Study of Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

16 мар 2021 07:00:00 Источник Nasdaq GlobeNewswire

FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results

01 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire

FibroGen Provides Regulatory Update on Roxadustat

01 мар 2021 16:01:00 Источник Nasdaq GlobeNewswire

FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results

18 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire

FibroGen to Present at Upcoming Investor Conferences

12 фев 2021 07:00:00 Источник Nasdaq GlobeNewswire